Inventor · disambiguated record
Byoung-Mog Kwon
Also filed as: KWON BYOUNG M · KWON BYOUNG-MOG
23 granted patents·13 pending applications·257 citations·filing 1994–2023
95Inventor score
Files withKOREA RES INST OF BIOSCIENCE16KOREA INST SCI & TECH7KWON BYOUNG MOG6KOREA RES INST BIOSCIENCE & BIOTECHNOLOGY3NAT UNIV CHONBUK IND COOP FOUND1
Top patents by PatentIndex Score
36 records- 0191US8754209B2Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredientSIM TAE BO·Filed 2009·Granted Jun 17, 2014·30 cites·8 claims
- 0286US5763414AHesperidin and hesperetin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitorKOREA INST SCI & TECH·Filed 1997·Granted Jun 9, 1998·53 cites·6 claims
- 0385US7250432B2Pharmaceutical compositions of diaryl-isoxazole derivatives for the prevention and treatment of cancersKOREA RES INST OF BIOSCIENCE·Filed 2004·Granted Jul 31, 2007·19 cites·3 claims
- 0483US5792461ACitrus peel extract as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase inhibitorKOREA INST SCI & TECH·Filed 1997·Granted Aug 11, 1998·46 cites·6 claims
- 0581US8716288B2Composition comprising benproperine derivatives as active ingredients for preventing and treating angiogenesis-related diseasesKWON BYOUNG MOG·Filed 2013·Granted May 6, 2014·7 cites·16 claims
- 0680US5877208ANaringin and naringenin as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase inhibitorKOREA INST SCI & TECH·Filed 1997·Granted Mar 2, 1999·36 cites·6 claims
- 0777US6165984ANaringin and naringenin as inhibitors of acyl CoA-cholesterol-o-acyltransferaseKOREA INST SCI & TECH·Filed 1998·Granted Dec 26, 2000·39 cites·10 claims
- 0876US6387948B18-Acetylarteminolide and process for preparing sameKOREA RES INST OF BIOSCIENCE·Filed 2000·Granted May 14, 2002·10 cites·1 claims
- 0971US7799811B2Agent for prevention and treatment of cancer comprising oxadiazole urea compound obstructing activity of statKOREA RES INST OF BIOSCIENCE·Filed 2007·Granted Sep 21, 2010·1 cites·2 claims
- 1067US9486490B2Composition for preventing or treating cancer containing extracts of artocarpus altilis fruits, leaves, or stems, or fractions thereof as active ingredientsKOREA RES INST BIOSCIENCE & BIOTECHNOLOGY·Filed 2013·Granted Nov 8, 2016·0 cites·4 claims
- 1165US6949682B2Cinnamaldehyde derivatives inhibiting growth of tumor cell and regulating cell cycle, preparations and pharmaceutical compositions thereofKOREA RES INST OF BIOSCIENCE·Filed 2004·Granted Sep 27, 2005·3 cites·5 claims
- 1265US2025082620A1Novel cinnamamide derivatives and use thereofKOREA RES INST BIOSCIENCE & BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 1361US5597835AAcyl CoA:cholesterol acyltransferase inhibitorsKOREA INST SCI & TECH·Filed 1994·Granted Jan 28, 1997·6 cites·3 claims
- 1459US2009263521A1Composition for the treatment of cancers and inhibition of metastasis containing extracts or fractions of the magnolia obovataKOREA RES INST OF BIOSCIENCE·Filed 2008·Application pending·0 cites
- 1559US2009311354A1Composition comprising extracts or fractions of magnolia obovata thunb for treating and preventing inflammation diseaseKOREA RES INST OF BIOSCIENCE·Filed 2008·Application pending·0 cites
- 1659US2007037889A1Anticancer composition comprising obovatol or obovatalKOREA RES INST OF BIOSCIENCE·Filed 2006·Application pending·0 cites
- 1758US8367736B2Anticancer composition comprising obovatol or obovatalKOREA RES INST OF BIOSCIENCE·Filed 2008·Granted Feb 5, 2013·0 cites·2 claims
- 1856US5801254AArteminolide derivatives and process for the manufacture thereofKOREA INST SCI & TECH·Filed 1997·Granted Sep 1, 1998·6 cites·3 claims
- 1954US8183405B2Obovatol derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for the prevention and treatment of cancer containing the same as an active ingredientKWON BYOUNG-MOG·Filed 2008·Granted May 22, 2012·0 cites·2 claims
- 2054US7939542B2Cinnamaldehyde derivatives having improved solubility in water, a method for preparing the same and a pharmaceutical composition comprising the sameKOREA RES INST OF BIOSCIENCE·Filed 2008·Granted May 10, 2011·0 cites·9 claims
- 2154US6808724B2Artemisolide compound isolated from the aerial parts of Artemisia sylvatica, isolation method, and use thereofKOREA RES INST OF BIOSCIENCE·Filed 2003·Granted Oct 26, 2004·1 cites·3 claims
- 2253US2006035968A1Composition for preventing cancer comprising 2'-benzoyl-oxycinnamaldehydeKOREA RES INST OF BIOSCIENCE·Filed 2004·Application pending·0 cites
- 2353US2010125103A1Composition for the treatment of diabetes and metabolic syndrome containing obovatol and its synthesized derivativesTG BIOTECH CO LTD·Filed 2009·Application pending·0 cites
- 2451US11945779B2Inhibitors of cancer metastasis through inhibiting migration and invasion of cancer cellsVSpharmtech·Filed 2019·Granted Apr 2, 2024·0 cites·8 claims
- 2547US9580399B2Geranyl flavonoid derivative with improved water solubility, a method for preparing the same, and a method for treating cancer using the sameKOREA RES INST BIOSCIENCE & BIOTECHNOLOGY·Filed 2015·Granted Feb 28, 2017·0 cites·9 claims
- 2646US9950071B2Hybrid anticancer prodrug simultaneously producing cinnamaldehyde and quinone methide and method for preparing sameNAT UNIV CHONBUK IND COOP FOUND·Filed 2015·Granted Apr 24, 2018·0 cites·15 claims
- 2745US2001002264A1Citrus peel extract as inhibitor of fatty streak formation on the arterial wallKOREA RES INST OF BIOSCIENCE·Filed 2000·Application pending·0 cites
- 2844US8268292B2Obovatol having anti-anxiety activityKWON BYOUNG MOG·Filed 2006·Granted Sep 18, 2012·0 cites·6 claims
- 2944US2007185215A1Pharmaceutical composition containing obovatol as an active ingredient for the prevention and treatment of neurodegenerative diseasesKWON BYOUNG-MOG·Filed 2006·Application pending·0 cites
- 3043US2009318376A1High Throughput Screening Method of Binding Inhibitor Between caspase3 and XIAP and Binding Inhibitor Screened TherebyKOREA RES INST OF BIOSCIENCE·Filed 2006·Application pending·0 cites
- 3143US2007160691A1Pharmaceutical composition for treating and preventing cancer comprising cinnamoni cortex extract and zizyphi fructus extractKOREA RES INST OF BIOSCIENCE·Filed 2004·Application pending·0 cites
- 3242US8865762B2Method for the treatment of bone diseases comprising colforsin daropateKWON BYOUNG MOG·Filed 2010·Granted Oct 21, 2014·0 cites·5 claims
- 3342US2008139668A1Pharmaceutical composition for obovatol for the prevention and treatment of restenosisKOREA RES INST OF BIOSCIENCE·Filed 2007·Application pending·0 cites
- 3440US6620938B1Compounds that inhibit GRB2-SHC binding and process for preparing sameKOREA RES INST OF BIOSCIENCE·Filed 2000·Granted Sep 16, 2003·0 cites·2 claims
- 3539US2016095845A1Composition comprising (s)-(-)-benproperine for preventing or treating cancerKWON BYOUNG MOG·Filed 2015·Application pending·0 cites
- 3638US2001014357A1Citrus peel extract as inhibitor of ACYL coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseasesKOREA INST SCI & TECH·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Byoung-Mog Kwon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →